{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T03:08:02Z","timestamp":1770692882983,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.lanwpc.2025.101495","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T22:31:57Z","timestamp":1739658717000},"page":"101495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Strategies for the prevention of ischemic stroke in atrial fibrillation in East Asia: clinical features, changes and challenges"],"prefix":"10.1016","volume":"56","author":[{"given":"Tze-Fan","family":"Chao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eue-Keun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7626-7751","authenticated-orcid":false,"given":"Yutao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Fat","family":"Tse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanwpc.2025.101495_bib1","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.chest.2017.03.048","article-title":"The global burden of atrial fibrillation and stroke: a systematic review of the clinical epidemiology of atrial fibrillation in Asia","volume":"152","author":"Bai","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.lanwpc.2025.101495_bib2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.chest.2017.10.001","article-title":"Lifetime risks, projected numbers, and adverse outcomes in Asian patients with atrial fibrillation: a report from the Taiwan nationwide AF cohort study","volume":"153","author":"Chao","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.lanwpc.2025.101495_bib3","article-title":"Atrial fibrillation: epidemiology, screening and digital health","volume":"37","author":"Linz","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.lanwpc.2025.101495_bib4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s11239-019-02019-0","article-title":"High incidence of under-treated atrial fibrillation: perspectives from an Asian Stroke Endovascular Thrombectomy Registry","volume":"49","author":"Tan","year":"2020","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.lanwpc.2025.101495_bib5","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/eurheartj\/ehy807","article-title":"Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial","volume":"40","author":"Chao","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lanwpc.2025.101495_bib6","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1055\/a-2269-1123","article-title":"Racial differences in bleeding risk: an ecological epidemiological study comparing Korea and United Kingdom subjects","volume":"124","author":"Kang","year":"2024","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lanwpc.2025.101495_bib7","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1055\/a-2278-8769","article-title":"Racial differences in ischemic and hemorrhagic stroke: an ecological epidemiological study","volume":"124","author":"Kang","year":"2024","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lanwpc.2025.101495_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-0041-1739411","article-title":"2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary","volume":"122","author":"Chao","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lanwpc.2025.101495_bib9","article-title":"Atrial fibrillation: stroke prevention","volume":"37","author":"Chao","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.lanwpc.2025.101495_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Writing Committee Members","year":"2024","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.lanwpc.2025.101495_bib11","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lanwpc.2025.101495_bib12","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jacc.2020.01.052","article-title":"Mobile health technology to improve care for patients with atrial fibrillation","volume":"75","author":"Guo","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.lanwpc.2025.101495_bib13","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jacasi.2024.07.006","article-title":"A\u00a0novel model of integrated care of older patients with atrial fibrillation in rural China","volume":"4","author":"Li","year":"2024","journal-title":"JACC Asia"},{"key":"10.1016\/j.lanwpc.2025.101495_bib14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/a-1515-9630","article-title":"Adherence to the \u2018atrial fibrillation better care\u2019 pathway in patients with atrial fibrillation: impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients","volume":"122","author":"Romiti","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lanwpc.2025.101495_bib15","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1093\/europace\/euab327","article-title":"Prognosis and treatment of atrial fibrillation in Asian cities: 1-year review of the Asia-Pacific Heart Rhythm Society Atrial Fibrillation Registry","volume":"24","author":"Tse","year":"2022","journal-title":"Europace"},{"issue":"5","key":"10.1016\/j.lanwpc.2025.101495_bib16","article-title":"Temporal trends of emergency department visits of patients with atrial fibrillation: a nationwide population-based study","volume":"9","author":"Lee","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.lanwpc.2025.101495_bib17","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1161\/CIRCULATIONAHA.118.036046","article-title":"Evolving changes of the use of oral anticoagulants and outcomes in patients with newly diagnosed atrial fibrillation in Taiwan","volume":"138","author":"Chao","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.lanwpc.2025.101495_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1378\/chest.14-2018","article-title":"Time trends of aspirin and warfarin use on stroke and bleeding events in Chinese patients with new-onset atrial fibrillation","volume":"148","author":"Guo","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.lanwpc.2025.101495_bib19","first-page":"475","article-title":"Underutilization of warfarin for stroke prophylaxis in patients with atrial fibrillation or atrial flutter in Korea","volume":"66","author":"Lee","year":"2015","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.lanwpc.2025.101495_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12959-023-00527-x","article-title":"Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry: trends in antithrombotic therapy use in China","volume":"21","author":"Liu","year":"2023","journal-title":"Thromb J"},{"key":"10.1016\/j.lanwpc.2025.101495_bib21","article-title":"Epidemiology, management, and outcomes of atrial fibrillation among 30 million citizens in Shanghai, China from 2015 to 2020: a medical insurance database study","volume":"23","author":"Chen","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.lanwpc.2025.101495_bib22","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1253\/circj.CJ-22-0023","article-title":"10-Year trends of antithrombotic therapy status and outcomes in Japanese Atrial fibrillation patients - the Fushimi AF registry","volume":"86","author":"Akao","year":"2022","journal-title":"Circ J"},{"key":"10.1016\/j.lanwpc.2025.101495_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/s42444-024-00120-x","article-title":"Atrial fibrillation fact sheet in Korea 2024: part 2 \u2014 stroke prevention in Korean patients with atrial fibrillation","volume":"25","author":"Yang","year":"2024","journal-title":"Int J Arrhythmia"},{"issue":"Issue Supplement_1","key":"10.1016\/j.lanwpc.2025.101495_bib24","article-title":"Temporal trends of prescription rates, dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in patients with atrial fibrillation","author":"Chao","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lanwpc.2025.101495_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/s42444-024-00119-4","article-title":"Atrial fibrillation fact sheet in Korea 2024 (part 1): epidemiology of atrial fibrillation in Korea","volume":"25","author":"Lee","year":"2024","journal-title":"Int J Arrhythmia"},{"key":"10.1016\/j.lanwpc.2025.101495_bib26","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jacasi.2023.08.007","article-title":"Direct oral anticoagulant dosing in patients with atrial fibrillation: an Asian perspective","volume":"3","author":"Chao","year":"2023","journal-title":"JACC Asia"},{"key":"10.1016\/j.lanwpc.2025.101495_bib27","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1016\/j.hrthm.2020.07.022","article-title":"Off-label dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation","volume":"17","author":"Chan","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.lanwpc.2025.101495_bib28","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jacasi.2023.04.008","article-title":"Integrated care for atrial fibrillation using the ABC pathway in the prospective APHRS-AF registry","volume":"3","author":"Bucci","year":"2023","journal-title":"JACC Asia"},{"key":"10.1016\/j.lanwpc.2025.101495_bib29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2017.10.085","article-title":"Relationship of aging and incident comorbidities to stroke risk in patients with atrial fibrillation","volume":"71","author":"Chao","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.lanwpc.2025.101495_bib30","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1055\/s-0038-1636534","article-title":"Incident risk factors and major bleeding in patients with atrial fibrillation treated with oral anticoagulants: a comparison of baseline, follow-up and delta HAS-BLED scores with an approach focused on modifiable bleeding risk factors","volume":"118","author":"Chao","year":"2018","journal-title":"Thromb Haemost"},{"issue":"9","key":"10.1016\/j.lanwpc.2025.101495_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae237","article-title":"Components of the Atrial fibrillation Better Care pathway for holistic care of patients with atrial fibrillation: a win ratio analysis from the COOL-AF registry","volume":"26","author":"Krittayaphong","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.lanwpc.2025.101495_bib32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mayocp.2020.08.042","article-title":"Non-vitamin K antagonist oral anticoagulants in elderly (>\/=85 years) patients with newly diagnosed atrial fibrillation: changing clinical practice and outcomes for stroke prevention in a nationwide cohort study","volume":"96","author":"Cheng","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.lanwpc.2025.101495_bib33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejim.2023.03.001","article-title":"Clinical outcomes of patients with incident atrial fibrillation diagnosed by cardiologists compared to non-cardiologists","volume":"112","author":"Liu","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.lanwpc.2025.101495_bib34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jacc.2007.01.098","article-title":"Racial\/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation","volume":"50","author":"Shen","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.lanwpc.2025.101495_bib35","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/ageing\/afr097","article-title":"Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review","volume":"40","author":"Pugh","year":"2011","journal-title":"Age Ageing"},{"key":"10.1016\/j.lanwpc.2025.101495_bib36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.amjmed.2017.10.036","article-title":"Apixaban for reduction in stroke other thromboembolic events in atrial fibrillation I. Clinical outcomes and history of fall in patients with atrial fibrillation treated with oral anticoagulation: Insights from the ARISTOTLE trial","volume":"131","author":"Rao","year":"2018","journal-title":"Am J Med"},{"key":"10.1016\/j.lanwpc.2025.101495_bib37","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1182\/blood-2016-08-731638","article-title":"Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy","volume":"129","author":"Lopes","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.lanwpc.2025.101495_bib38","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1056\/NEJMoa2012883","article-title":"Low-dose edoxaban in very elderly patients with atrial fibrillation","volume":"383","author":"Okumura","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.lanwpc.2025.101495_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102039","article-title":"Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry","volume":"63","author":"Romiti","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.lanwpc.2025.101495_bib40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00392-021-01816-z","article-title":"Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation","volume":"111","author":"Chao","year":"2022","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.lanwpc.2025.101495_bib41","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/STROKEAHA.113.002968","article-title":"Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial","volume":"45","author":"Wong","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.lanwpc.2025.101495_bib42","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ahj.2014.06.005","article-title":"Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial","volume":"168","author":"Goto","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.lanwpc.2025.101495_bib43","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1253\/circj.CJ-15-1082","article-title":"Edoxaban vs. warfarin in East Asian patients with atrial fibrillation - an ENGAGE AF-TIMI 48 subanalysis","volume":"80","author":"Yamashita","year":"2016","journal-title":"Circ J"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266660652500032X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266660652500032X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T19:08:29Z","timestamp":1745003309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266660652500032X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":43,"alternative-id":["S266660652500032X"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2025.101495","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies for the prevention of ischemic stroke in atrial fibrillation in East Asia: clinical features, changes and challenges","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2025.101495","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101495"}}